Compositions and methods comprising KLK3 or FOLH1 antigen
US11446369B2 · kind B2 · utility
3Cited by
73References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 1, 2019 |
| Grant date | Sep 20, 2022 |
| Priority date | — |
| Expiry date | Jun 1, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/40
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides KLK3 peptides, FOLH1 peptides, recombinant polypeptides comprising same, recombinant nucleotide molecules encoding same, recombinant Listeria strains comprising same, and immunogenic and therapeutic methods utilizing same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.